Prosecution Insights
Last updated: April 19, 2026
Application No. 15/577,681

Methods and Systems for Treating Neurological Movement Disorders

Final Rejection §112
Filed
Nov 28, 2017
Examiner
BERHANU, ETSUB D
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Regents of the University of California
OA Round
11 (Final)
66%
Grant Probability
Favorable
12-13
OA Rounds
3y 6m
To Grant
90%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
516 granted / 787 resolved
-4.4% vs TC avg
Strong +24% interview lift
Without
With
+24.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
50 currently pending
Career history
837
Total Applications
across all art units

Statute-Specific Performance

§101
16.6%
-23.4% vs TC avg
§103
33.3%
-6.7% vs TC avg
§102
12.4%
-27.6% vs TC avg
§112
29.1%
-10.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 787 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 2, 4, 6, 7, 51-57, 59, and 60 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The originally filed disclosure fails to provide support for a method comprising producing second electrical activity from recorded first electrical activity, wherein the second electrical activity is expressed as a function of frequency and each frequency of the second electrical activity is within the range of 60 Hz to 90 Hz. The originally filed disclosure does not support producing second electrical activity only within the range of 60 Hz to 90 Hz. When first electrical activity outside of the 60 Hz to 90 Hz range is recorded, how would second electrical activity within the range of 60 Hz to 90 Hz be produced? The originally filed disclosure fails to provide any written description that indicates that, at the time the invention was effectively filed, the inventors were in possession of a method that produces second electrical activity within the range of 60 Hz to 90 Hz from first electrical activity that is outside of that 60 Hz to 90 Hz range. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 2, 4, 6, 7, 51-57, 59, and 60 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites a method comprising recording first electrical activity, and producing second electrical activity from the recorded first electrical activity, wherein the second electrical activity is expressed as a function of frequency and each frequency of the second electrical activity is within the range of 60 Hz to 90 Hz. It is unclear how second electrical activity within a range of 60 Hz to 90 Hz would be produced from first electrical activity recorded outside of that 60 Hz to 90 Hz range. Furthermore, the claim later calls for modifying the treatment of the patient based only on when the second electrical activity has oscillatory activity in the range of 60 Hz to 90 Hz. According to the producing step in the claimed method, only second electrical activity within a 60 Hz to 90 Hz range is produced. If only 60 Hz to 90 Hz oscillatory brain activity is being produced, then the treatment will always be modified. Response to Arguments Applicant's arguments filed 22 October 2025 have been fully considered and they are not persuasive. The Examiner maintains that the originally filed specification fails to provide support for producing second electrical activity from recorded first electrical activity, wherein each frequency of the second electrical activity is within the range of 60 Hz to 90 Hz. The Examiner also maintains that it is unclear how second electrical activity having frequencies within the range of 60 Hz to 90 Hz would be produced from recorded first electrical activity that does not include frequency components within the range of 60 Hz to 90 Hz. Applicant appears to rely on Fourier Transforms to provide both support and clarity for the claimed subject matter. Applicant’s arguments are not persuasive as Fourier Transforms transform time domain signals into a signal in the frequency domain that represents the existing frequency components of the time domain signal. Fourier Transforms are used to analyze the already existing frequency components of a time domain signal; they do not create frequency components that are not present in the original time domain signal, nor do they remove frequency components that are present in the original time domain signal. If an original time domain signal does not contain any frequency components within the range of 60 Hz to 90 Hz, its equivalent frequency domain signal will not comprise 60 Hz to 90 Hz values (a typical frequency domain conversion results in an x-axis Frequency vs. y-axis Amplitude graph, the “values” being the y-axis amplitude values). If an original time domain signal contains frequency components outside of a 60 Hz to 90 Hz range, its equivalent frequency domain signal will comprise values corresponding to frequency components outside of that 60 Hz to 90 Hz range. In other words, if the recorded first electrical activity signal comprises a 100 Hz frequency component, performing a Fourier Transform on the first electrical activity signal would produce a second electrical activity signal with an amplitude value at a frequency outside of the range of 60 Hz to 90 Hz (it would produce a second electrical activity signal having an amplitude value greater than 0 at 100 Hz). For a time domain signal with no frequency components in the 60 Hz to 90 Hz range, calculating a Fourier Transform of the time domain signal at “frequencies of 60.0, 60.1, 60.2 … 89.8, 89.9, and 90.0 Hz” would result in a value of “0” for each frequency; no second electrical activity would be produced. While the prior art does not teach a method comprising producing only second electrical activity within a 60 Hz to 90 Hz range, the claims are not allowable due to the rejections under 35 U.S.C. 112(a) and 35 U.S.C. 112(b). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Afshar et al.’447 (US Pub No. 2015/0202447 – previously cited) discloses a method of treating a movement disorder in a human patient, the method comprising: recording first electrical activity as a function of time with leads, wherein each of the leads used to record the first electrical activity is placed at the motor cortex or the subthalamic nucleus (STN), wherein the patient is receiving a treatment for the movement disorder; producing second electrical activity from the recorded first electrical activity, wherein the second electrical activity is expressed as a function of frequency; modifying the treatment of the patient based only on when the second electrical activity has oscillatory activity in the range of 60Hz to 90Hz in both the motor cortex and the STN; wherein the treatment comprises deep brain stimulation; and wherein modifying the treatment comprises adjusting a parameter of the deep brain stimulation. Halje et al. (Levodopa-Induced Dyskinesia… – previously cited) discloses a method similar to the one taught by Afshar et al.’447. Simonin et al. (Reduced levodopa-induced complications… – previously cited) teaches that levodopa-induced dyskinesia decreases with the use of subthalamic nucleus deep brain stimulation. Molnar et al.’674 (US Pub No. 2007/0225674 – previously cited) specifically teaches measuring LFPs from an STN and using the LFP recordings to define a biomarker that can be monitored to assess a patient’s neurological movement disorder (sections [0026] and [0028]). Giannicola et al. (The effects of levodopa and ongoing deep brain stimulation… – previously cited) teaches recording LFPs in the STN for individuals with Parkinson’s disease. The paper examines the combined effect of levodopa and deep brain stimulation on STN beta LFP oscillations (which requires measuring LFP oscillations in the STN). Rizzone et al. (Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease… – previously cited) teaches treating Parkinson’s disease with deep brain stimulation of the subthalamic nucleus, and further discloses adjusting the parameters of the stimulation in order to provide the most effective therapy to a patient. A number of references cited by the Applicant also teach measuring oscillatory activity with a lead placed at the STN in patients suffering from neurological movement disorders. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ETSUB D BERHANU whose telephone number is (571)270-5410. The examiner can normally be reached Mon-Fri 9:00am-5:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ETSUB D BERHANU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Nov 28, 2017
Application Filed
Dec 20, 2019
Non-Final Rejection — §112
Mar 24, 2020
Response Filed
Jun 18, 2020
Final Rejection — §112
Aug 10, 2020
Response after Non-Final Action
Aug 20, 2020
Examiner Interview (Telephonic)
Aug 21, 2020
Response after Non-Final Action
Aug 31, 2020
Request for Continued Examination
Sep 04, 2020
Response after Non-Final Action
Sep 28, 2020
Non-Final Rejection — §112
Dec 18, 2020
Response Filed
Mar 26, 2021
Final Rejection — §112
May 14, 2021
Response after Non-Final Action
Jun 25, 2021
Notice of Allowance
Aug 25, 2021
Response after Non-Final Action
Sep 07, 2021
Response after Non-Final Action
Oct 21, 2021
Response after Non-Final Action
Jan 03, 2022
Response after Non-Final Action
Jan 10, 2022
Response after Non-Final Action
Jan 11, 2022
Response after Non-Final Action
Jan 11, 2022
Response after Non-Final Action
Nov 22, 2022
Response after Non-Final Action
Jan 26, 2023
Non-Final Rejection — §112
May 17, 2023
Response Filed
Jul 03, 2023
Final Rejection — §112
Sep 11, 2023
Response after Non-Final Action
Nov 09, 2023
Request for Continued Examination
Nov 21, 2023
Response after Non-Final Action
Nov 24, 2023
Final Rejection — §112
Mar 19, 2024
Request for Continued Examination
Mar 28, 2024
Response after Non-Final Action
Apr 15, 2024
Non-Final Rejection — §112
Aug 20, 2024
Response Filed
Sep 06, 2024
Final Rejection — §112
Dec 05, 2024
Interview Requested
Dec 17, 2024
Examiner Interview Summary
Mar 06, 2025
Notice of Allowance
Apr 28, 2025
Request for Continued Examination
Apr 30, 2025
Response after Non-Final Action
Jul 23, 2025
Non-Final Rejection — §112
Oct 22, 2025
Response Filed
Nov 30, 2025
Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12593163
METHOD AND SYSTEM FOR COLLECTING AND PROCESSING BIOELECTRICAL AND AUDIO SIGNALS
2y 5m to grant Granted Mar 31, 2026
Patent 12582357
Closed System Flexible Vascular Access Device Sensor Deployment System
2y 5m to grant Granted Mar 24, 2026
Patent 12575742
Non-Invasive Venous Waveform Analysis for Evaluating a Subject
2y 5m to grant Granted Mar 17, 2026
Patent 12569269
BENDABLE CUTTING APPARATUS FOR MYOCARDIUM AND SYSTEM WITH THE SAME
2y 5m to grant Granted Mar 10, 2026
Patent 12558017
METHODS FOR MODELING NEUROLOGICAL DEVELOPMENT AND DIAGNOSING A NEUROLOGICAL IMPAIRMENT OF A PATIENT
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

12-13
Expected OA Rounds
66%
Grant Probability
90%
With Interview (+24.5%)
3y 6m
Median Time to Grant
High
PTA Risk
Based on 787 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month